Thomas supported his mother through two breast cancer diagnoses, maintaining his routine and using art to cope. As we’re ...

CURE spoke with Dr. Marina Kremyanskaya about the treatment landscape for patients with polycythemia vera.

A diagnosis of triple-negative breast cancer is typically made after a biopsy confirms the tumor’s receptor status. Imaging ...

Bernadette, a stage 4 cancer patient, inspires others with her faith and optimism, becoming a mentor within her support group. She participates in a promising drug trial using T cell therapy to ...

Smoking cessation in advanced-stage cancer patients can extend life by about one year, highlighting its importance in cancer ...

Research is underway for an experimental treatment for patients with succinate dehydrogenase (SDH) deficient gastrointestinal ...

Baker, who is based in the United Kingdom, recently sat down for an interview with CURE alongside Dr. Marina Kremyanskaya, ...

Stage 1 PV management includes phlebotomy, low-dose aspirin, cytoreductive therapy, and lifestyle changes to prevent complications. Stage 1 polycythemia vera is manageable with monitoring, phlebotomy, ...

Immunotherapies, such as the blockbuster immune checkpoint inhibitor drug Keytruda (pembrolizumab), work by keeping cancer cells from suppressing a patient’s immune system and thus allowing the immune ...

Surviving breast cancer heightens awareness of bodily changes, with new symptoms potentially triggering fears of recurrence.

Squamous cell carcinoma (SCC) of the bladder is a distinct and rarer form, accounting for approximately 2% to 5% of all bladder cancers in the U.S. It develops in the flat, thin squamous cells that ...

The FDA granted fast track designation to AVZO-103 for the treatment of patients with previously treated locally advanced or metastatic urothelial cancer.